Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
14m agoRyl Tea Debuts Zero-Sugar Iced Teas Inspired by Iconic Jolly Rancher Candy Flavors
15m agoInspira Technologies Secures Fully Paid $390,000 Purchase Order and Recurring Revenue Stream from Premier APAC University
15m agoAutris to Host "Land, Lifestyle, and Bitcoin" Virtual Investor Webinar on April 28, 2026
16m agoNeusoft and AISpeech Forge In-depth Partnership to Jointly Build a Global AI Mobility Ecosystem
16m agoSilexion Therapeutics Announces Successful Submission of Phase 2/3 Clinical Trial Application to Germany’s BfArM for SIL204 in KRAS-Driven Locally Advanced Pancreatic Cancer

Percheron Therapeutics Limited

About

Percheron Therapeutics Limited (AU:PER) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 14 2026
Results of Entitlement Offer
Mar 16 2026
Prospectus - Non-renounceable Entitlement Offer
Mar 16 2026
Non-renounceable Entitlement Offer
Feb 26 2026
Half Yearly Report and Accounts
Jan 30 2026
Quarterly Activities/Appendix 4C Cash Flow Report

Financials

Revenue
A$1.74 M
Market Cap
A$6.52 M
EPS
-0.01

Community Chat

Ask AI

6ix6ixAIEvents